Institutional Ownership
Bicycle Therapeutics PLC
CUSIP 088786108SPONSORED ADSBCYCQ1 2026
13D / 13G Filings
59
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
22.9%
Max % of class reported
Institutional Holders
97
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
59 filings · latest Mar 4, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 4, 2026 | Westfield Capital Management Company, L.P. | 13G/A | — | — | SEC |
| 2 | Mar 3, 2026 | Invus Public Equities, L.P. | 13G | 6.3% | 3.15M | SEC |
| 3 | Mar 3, 2026 | Westfield Capital Management Company, L.P. | 13G/A | — | — | SEC |
| 4 | Mar 3, 2026 | Westfield Capital Management Company, L.P. | 13G/A | — | — | SEC |
| 5 | Feb 18, 2026 | Armistice Capital, LLC | 13G | 6.5% | 3.24M | SEC |
| 6 | Feb 11, 2026 | Westfield Capital Management Company, L.P. | 13G/A | 6.0% | 3.02M | SEC |
| 7 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 2.28M | SEC |
| 8 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 2.4% | 1.20M | SEC |
| 9 | Aug 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 3.9% | 1.86M | SEC |
| 10 | May 15, 2025 | Armistice Capital, LLC | 13G | 5.6% | 2.67M | SEC |
49 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Bicycle Therapeutics PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 10.89M | $50.51M |
| 2 | Fcpm III Services B.V. | 3.47M | $16.09M |
| 3 | Armistice Capital, LLC | 3.40M | $15.77M |
| 4 | Long Focus Capital Management, LLC | 3.31M | $15.36M |
| 5 | Siren, L.L.C. | 1.56M | $7.24M |
| 6 | Gsk PLC | 1.53M | $7.10M |
| 7 | Principal Financial Group Inc | 1.17M | $5.45M |
| 8 | Renaissance Technologies LLC | 979.3K | $4.54M |
| 9 | Morgan Stanley | 618.3K | $2.87M |
| 10 | Schroder Investment Management Group | 615.8K | $2.67M |